08|06|26

What ChatGPT Ads Mean for Pharma Search

Explore the critical differences between ChatGPT Ads and standard search, the unique regulatory challenges ahead, and the exact steps pharma brands must take now to prepare for inevitable platform access.

08|04|26

From Outputs to Outcomes: Mike Guarino on the Future of Commercialization

What does it take to be a true "category of one" in today's rapidly evolving healthcare landscape? In this Fierce Pharma interview, EVERSANA INTOUCH CEO Mike Guarino discusses the shift from outputs to outcomes, the growing role of AI in commercialization, and why the competitive advantage isn't data alone, but the stories it helps brands tell. Watch the interview excerpt to hear his perspective on the future of healthcare commercialization.

07|30|26

Preparing for FDA’s Proposed DTC Broadcast Overhaul

A proposed FDA rule could significantly reshape the future of direct-to-consumer (DTC) pharmaceutical advertising, prompting life sciences brands to rethink how they reach and engage patients. In our latest point of view, Dave Leitner, EVP, Head of Media, explores the potential impact of the FDA’s proposal to eliminate the long-standing “adequate provision” standard for broadcast […]

07|29|26

Omnideployment: The Future of Pharmaceutical Commercialization

Discover how omnideployment is helping pharmaceutical organizations connect digital engagement, AI-powered content and field execution to drive smarter HCP interactions, stronger engagement and better outcomes.

07|16|26

Webinar Recap: What Pharma Can Learn From Cannes Lions 2026

What can pharma marketers learn from the most awarded creative work in the world? Watch the recording of our recent Cannes Lions webinar to discover the standout campaigns, emerging themes and practical lessons shaping the future of marketing.

07|09|26

Human Scarcity in an AI-First World: Cannes Lions 2026

In a world flooded with AI-generated content, the brands that stand out are proving their humanity. Discover five insights from Cannes Lions 2026 that every pharma marketer should know.

07|06|26

Beyond the AI Hype: Why Authentic Connection Dominated Cannes 2026

At Cannes Lions 2026, the conversation wasn't about replacing humans with AI—it was about amplifying what makes us human. Susan Perlbachs, Chief Creative Officer, explores the rise of Human Maxing and the lessons shaping the future of creativity.

06|23|26

The Omnichannel Evolution: Are You Still Using Yesterday’s Playbook? 

The landscape of healthcare marketing is shifting faster than ever, and the strategies that drove success just a few years ago are rapidly becoming obsolete.  In a recent article for PM360, Dan Gandor, EVP, Head of Omnichannel & Digital Transformation, breaks down exactly how and why the optimal omnichannel mix has evolved.

06|23|26

Navigating the New Era of Pharma Search with Google AI Overviews 

As Google AI Overviews increasingly become the front door for pharmaceutical discovery, life science brands must adapt their strategies to maintain visibility in a changing search landscape.  Josie Black, Head of SEO and GEO, explored this rapid shift to AI-powered, synthesized answers in discussion with pharmaphorum.

06|11|26

Beyond the Molecule: The New Reality of Oncology Commercialization 

As ASCO 2026 made clear, oncology has entered a “post-molecule” era, where clinical efficacy is no longer the primary differentiator, but a baseline expectation. In a new article for PharmaLive, Tim Lewis explores how success now depends on how well therapies integrate into an increasingly complex, overburdened care ecosystem.